Distribution of particles which produces a desired radiation pattern

A.G.Ramm

DOI: https://doi.org/10.48550/arXiv.math-ph/0507006

2005-07-02

Abstract:A method is given for calculation of a distribution of small particles, embedded in a medium, so that the resulting medium would have a desired radiation pattern for the plane wave scattering by this medium.

Mathematical Physics

What problem does this paper attempt to address?

Telomere control of replicative lifespan

G B Morin

DOI: https://doi.org/10.1016/s0531-5565(96)00164-7

Abstract:The replicative capacity of cells may limit the lifespan of key systems in the body. It has long been known that normal human cells have a finite lifespan when placed in cell culture, and their lifespan is dependent on the age of the individual donor. The mechanism of the genetic program that times this process has been elusive. The telomere hypothesis of cell aging proposes that the length of the telomeric repeat array at chromosomal termini can time replication number and signal cell cycle arrest when critical telomere lengths are obtained. The erosion of telomeric DNA in normal tissues appears to be due to the lack of expression of components of the telomere maintenance system. Telomerase, the key enzyme involved in telomere replication, is not expressed in somatic tissues, but is expressed in germ cells, where telomere length is stably maintained, so that viable chromosomes can be transmitted to the next generation. Evidence is reviewed that correlates telomere length, telomerase activity, and the manipulation of telomere length with cell replicative capacity and cellular immortalization. Strong circumstantial evidence exists that indicates a role for telomere biology in the control of replicative capacity and in tumorigenesis.
Telomere length maintenance in aging and carcinogenesis.

M Aragona,R Maisano,S Panetta,A Giudice,M Morelli,I La Torre,F La Torre

DOI: https://doi.org/10.3892/ijo.17.5.981

2000-11-01

International Journal of Oncology

Abstract:Normal somatic cells have a finite number of divisions, a limited capacity to proliferate. Human telomeres, the long DNA TTAGGG repeats at the ends of chromosomes, are considered a molecular clock marker. The gradual and progressive telomere shortening at each replicative cycle is associated, through the activation of pRB and p53 pathways and genomic instability, to the replicative senescence, a non-dividing state and widespread cell death. Activation of telomere maintenance [telomerase; or alternative lengthening of telomeres mechanisms (ALT), or other adaptive responses] can revert this program. Although not completely known, several mechanisms and modulating agents may be able to up and down-regulate telomere length and its maintenance. Chemopreventive therapies for the up-regulation of telomerase activity, able to prolong the life of cell cultures in a phenotypically youthful state, could have important applications in research and medicine. On the contrary the therapeutic down-regulation of telomerase activity may be used in cancer therapy. Telomerase expression per se is not oncogenic, but telomere shortening and maintenance seem to be crucial events in tumor formation. Thus a particular focus has been pointed out relatively to the immortalization of normal or potential pre-cancerous cells. With the extension of life span the probability to get in contact with carcinogens increases, genetic instability, oncogene activation and/or onco-suppressor gene inactivation (i.e. p53, pRB, ras): the cancer transformation can be then induced in predisposed cells, depending on their genetic context, by the activation of telomere maintenance. Pharmacological intervention may be able to modulate the rate of living, by increasing life span of few specific target cells, or decreasing it in proliferating <cancer and pre-cancer cells>. Because of the unknown state of the enormous cell number of the human organism, is it safe to extend the human life span by therapeutic agents?

oncology
Moderate stem cell telomere shortening rate postpones cancer onset in stochastic model

Simon Holbek,Kristian Moss Bendtsen,Jeppe Juul

DOI: https://doi.org/10.48550/arXiv.1305.4264

2013-05-18

Cell Behavior

Abstract:Mammalian cells are restricted from proliferating indefinitely. Telomeres at the end of each chromosome are shortened at cell division and, when they reach a critical length, the cell will enter permanent cell cycle arrest - a state known as senescence. This mechanism is thought to be tumor suppressing, as it helps prevent precancerous cells from dividing uncontrollably. Stem cells express the enzyme telomerase, which elongates the telomeres, thereby postponing senescence. However, unlike germ cells and most types of cancer cells, stem cells only express telomerase at levels insufficient to fully maintain the length of their telomeres leading to a slow decline in proliferation potential. It is not yet fully understood how this decline influences the risk of cancer and the longevity of the organism. We here develop a stochastic model to explore the role of telomere dynamics in relation to both senescence and cancer. The model describes the accumulation of cancerous mutations in a multicellular organism and creates a coherent theoretical framework for interpreting the results of several recent experiments on telomerase regulation. We demonstrate that the longest average cancer free life span before cancer onset is obtained when stem cells start with relatively long telomeres that are shortened at a steady rate at cell division. Furthermore, the risk of cancer early in life can be reduced by having a short initial telomere length. Finally, our model suggests that evolution will favour a shorter than optimal average cancer free life span in order to postpone cancer onset until late in life.
On the comparative biology of mammalian telomeres: Telomere length co-evolves with body mass, lifespan and cancer risk

Michael Le Pepke,Dan T A Eisenberg

DOI: https://doi.org/10.1111/mec.15870

Abstract:Telomeres, the short repetitive DNA sequences that cap the ends of linear chromosomes, shorten during cell division and are implicated in senescence in most species. Telomerase can rebuild telomeres but is repressed in many mammals that exhibit replicative senescence, presumably as a tumour suppression mechanism. It is therefore important to understand the co-evolution of telomere biology and life-history traits that has shaped the diversity of senescence patterns across species. Gomes et al. previously produced a large data set on telomere length (TL), telomerase activity, body mass and lifespan among 57 mammal species. We re-analysed their data using the same phylogenetic multiple regressions and with several additional analyses to test the robustness of the findings. We found substantial inconsistencies in our results compared to Gomes et al.'s. Consistent with Gomes et al. we found an inverse association between TL and lifespan. Contrary to the analyses in Gomes et al., we found a generally robust inverse association between TL and mass, and only weak nonrobust evidence for an association between telomerase activity and mass. These results suggest that shorter TL may have been selected for in larger and longer lived species, probably as a mechanism to suppress cancer. We support this hypothesis by showing that longer telomeres predict higher cancer risk across 22 species. Furthermore, we find that domesticated species have longer telomeres. Our results call into question past interpretations of the co-evolution of telomere biology and life-history traits and stress the need for careful attention to model construction.
Telomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan.

Daojun Diao,Hu Wang,Tangliang Li,Zhencan Shi,Xiaoqing Jin,Tobias Sperka,Xudong Zhu,Meimei Zhang,Fan Yang,Yusheng Cong,Li Shen,Qimin Zhan,Jing Yan,Zhangfa Song,Zhenyu Ju

DOI: https://doi.org/10.15252/embr.201745494

IF: 9.071

2018-01-01

EMBO Reports

Abstract:Progressive attrition of telomeres triggers DNA damage response (DDR) and limits the regenerative capacity of adult stem cells during mammalian aging. Intriguingly, telomere integrity is not only determined by telomere length but also by the epigenetic status of telomeric/sub-telomeric regions. However, the functional interplay between DDR induced by telomere shortening and epigenetic modifications in aging remains unclear. Here, we show that deletion of Gadd45a improves the maintenance and function of intestinal stem cells (ISCs) and prolongs lifespan of telomerase-deficient mice (G3Terc(-/-)). Mechanistically, Gadd45a facilitates the generation of a permissive chromatin state for DDR signaling by inducing base excision repair-dependent demethylation of CpG islands specifically at sub-telomeric regions of short telomeres. Deletion of Gadd45a promotes chromatin compaction in sub-telomeric regions and attenuates DDR initiation at short telomeres of G3Terc(-/-) ISCs. Treatment with a small molecule inhibitor of base excision repair reduces DDR and improves the maintenance and function of G3Terc(-/-) ISCs. Taken together, our study proposes a therapeutic approach to enhance stem cell function and prolong lifespan by targeting epigenetic modifiers.
Telomeres, aging and cancer: In search of a happy ending

Sahn-ho Kim,Patrick Kaminker,Judith Campisi

DOI: https://doi.org/10.1038/sj.onc.1205077

IF: 8.756

2002-01-21

Oncogene

Abstract:Telomeres are distinctive structures, composed of a repetitive DNA sequence and associated proteins, that cap the ends of linear chromosomes. Telomeres are essential for maintaining the integrity and stability of eukaryotic genomes. In addition, under some circumstances, telomeres can influence cellular gene expression. In mammals, the length, structure, and function of telomeres have been proposed to contribute to cellular and organismal phenotypes associated with cancer and aging. Here, we discuss what is known about the basis for the links between telomeres, aging and cancer, and some of the known and proposed consequences of telomere dysfunction and maintenance for mammalian cells and organisms.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Telomere shortening and ageing

H. Jiang,Z. Ju,K. L. Rudolph

DOI: https://doi.org/10.1007/s00391-007-0480-0

2007-01-01

Abstract:Telomeres form the ends of human chromosomes. Telomeres shorten with each round of cell division and this mechanism limits proliferation of human cells to a finite number of cell divisions by inducing replicative senescence, differentiation, or apoptosis. Telomere shortening can act as a tumor suppressor. However, as a downside, there is growing evidence indicating that telomere shortening also limits stem cell function, regeneration, and organ maintenance during ageing. Moreover, telomere shortening during ageing and disease is associated with increasing cancer risk. In this review we summarize our current knowledge on the role of telomere shortening in human ageing, chronic diseases, and cancer.
Telomere Length Dynamics and the Evolution of Cancer Genome Architecture

Kez Cleal,Kevin Norris,Duncan Baird

DOI: https://doi.org/10.3390/ijms19020482

IF: 5.6

2018-02-06

International Journal of Molecular Sciences

Abstract:Telomeres are progressively eroded during repeated rounds of cell division due to the end replication problem but also undergo additional more substantial stochastic shortening events. In most cases, shortened telomeres induce a cell-cycle arrest or trigger apoptosis, although for those cells that bypass such signals during tumour progression, a critical length threshold is reached at which telomere dysfunction may ensue. Dysfunction of the telomere nucleoprotein complex can expose free chromosome ends to the DNA double-strand break (DSB) repair machinery, leading to telomere fusion with both telomeric and non-telomeric loci. The consequences of telomere fusions in promoting genome instability have long been appreciated through the breakage–fusion–bridge (BFB) cycle mechanism, although recent studies using high-throughput sequencing technologies have uncovered evidence of involvement in a wider spectrum of genomic rearrangements including chromothripsis. A critical step in cancer progression is the transition of a clone to immortality, through the stabilisation of the telomere repeat array. This can be achieved via the reactivation of telomerase, or the induction of the alternative lengthening of telomeres (ALT) pathway. Whilst telomere dysfunction may promote genome instability and tumour progression, by limiting the replicative potential of a cell and enforcing senescence, telomere shortening can act as a tumour suppressor mechanism. However, the burden of senescent cells has also been implicated as a driver of ageing and age-related pathology, and in the promotion of cancer through inflammatory signalling. Considering the critical role of telomere length in governing cancer biology, we review questions related to the prognostic value of studying the dynamics of telomere shortening and fusion, and discuss mechanisms and consequences of telomere-induced genome rearrangements.

biochemistry & molecular biology,chemistry, multidisciplinary
Mouse Model: Telomeres and Telomerase in Stem Cell and Cancer

Xin Huang,Zhenyu Ju

DOI: https://doi.org/10.1007/978-1-60327-879-9_6

2009-01-01

Abstract: Ageing is characterized by declines of adult stem cell function and regenerative reserves. The telomere has been regarded as a mitotic clock that controls cellular ageing. Telomeres are nucleoprotein complexes that consist of simple DNA repeats and associated binding proteins. In the absence of telomerase activity, telomere shortening occurs with each round of cell division. Critically short telomeres (dysfunctional telomeres) can be detected as DNA double strand breaks, thus activating DNA damage pathway and lead to cell cycle arrest, or, in some cases, apoptosis. Independent lines of evidence indicate that telomere dysfunction induces both cell intrinsic checkpoint and cell extrinsic checkpoint leading to an age-associated stem cell dysfunction. Genetically modified mice lacking telomerase activity proved an invaluable model for probing the in vivo consequences of replicative senescence and telomere-based stem cell ageing. Disturbing genes that regulate DNA damage checkpoints in response to telomere dysfunction partially rescued the degenerative phenotypes and ageing of adult stem cells, but in some cases increased tumorigenesis. Emerging evidence indicates that fine-tuning DNA damage checkpoints in response to telomere dysfunction could improve adult stem cell function, and meanwhile keep the tumor suppression mechanisms intact. Therefore, understanding the in vivo function of genes regulating telomere dysfunction during ageing could have important implication for regenerative medicine and cancer therapies.
How Will Telomeric Complex Be Further Contributed to Our Longevity? — the Potential Novel Biomarkers of Telomere Complex Counteracting Both Aging and Cancer

Yiming Lu,Bohua Wei,Tao Zhang,Zi Chen,Jing Ye

DOI: https://doi.org/10.1007/s13238-013-3002-4

2013-01-01

Protein & Cell

Abstract:With the smooth move towards the coming expected clinical reports of anticancer pharmaceutical molecules targeting telomeres and telomerase, and also with the exciting success in the extension of lifespan by regulating telomerase activity without increased onset of oncogenesis in laboratory mouse models (Garcia-Cao et al., 2006; Jaskelioff et al., 2011), we are convinced that targeting telomeres based on telomerase will be a potential approach to conquer both aging and cancer and the idea of longevity seems to be no more mysterious. More interestingly, emerging evidences from clinical research reveal that other telomeric factors, like specific telomeric binding proteins and nonspecific telomere associated proteins also show crucial importance in aging and oncogenesis. This stems from their roles in the stability of telomere structure and in the inhibition of DNA damage response at telomeres. Uncapping these proteins from chromosome ends leads to dramatic telomere loss and telomere dysfunction which is more abrupt than those induced by telomerase inactivation. Abnormal expression of these factors results in developmental failure, aging and even oncogenesis evidenced by several experimental models and clinical cases, indicating telomere specific proteins and its associated proteins have complimentary roles to telomerase in telomere protection and controlling cellular fate. Thus, these telomeric factors might be potential clinical biomarkers for early detection or even therapeutic targets of aging and cancer. Future studies to elucidate how these proteins function in telomere protection might benefit patients suffering aging or cancer who are not sensitive to telomerase mediation.
Telomere length, stem cells and aging

Maria A Blasco

DOI: https://doi.org/10.1038/nchembio.2007.38

IF: 14.8

2007-09-17

Nature Chemical Biology

Abstract:Telomere shortening occurs concomitant with organismal aging, and it is accelerated in the context of human diseases associated with mutations in telomerase, such as some cases of dyskeratosis congenita, idiopathic pulmonary fibrosis and aplastic anemia. People with these diseases, as well as Terc-deficient mice, show decreased lifespan coincidental with a premature loss of tissue renewal, which suggests that telomerase is rate-limiting for tissue homeostasis and organismal survival. These findings have gained special relevance as they suggest that telomerase activity and telomere length can directly affect the ability of stem cells to regenerate tissues. If this is true, stem cell dysfunction provoked by telomere shortening may be one of the mechanisms responsible for organismal aging in both humans and mice. Here, we will review the current evidence linking telomere shortening to aging and stem cell dysfunction.

biochemistry & molecular biology
Telomere length: how the length makes a difference

M. Lulkiewicz,J. Bajsert,P. Kopczynski,W. Barczak,B. Rubis

DOI: https://doi.org/10.1007/s11033-020-05551-y

IF: 2.7422

2020-09-01

Molecular Biology Reports

Abstract:Abstract Telomerase is perceived as an immortality enzyme that might provide longevity to cells and whole organisms. Importantly, it is generally inactive in most somatic cells of healthy, adult men. Consequently, its substrates, i.e. telomeres, get shorter in most human cells with time. Noteworthy, cell life limitation due to telomere attrition during cell divisions, may not be as bad as it looks since longer cell life means longer exposition to harmful factors. Consequently, telomere length (attrition rate) becomes a factor that is responsible for inducing the signaling that leads to the elimination of cells that lived long enough to acquire severe damage. It seems that telomere length that depends on many different factors (including telomerase activity but also genetic factors, a hormonal profile that reflects sex, etc.) might become a useful marker of aging and exposition to stress. Thus in the current paper, we review the factors that affect telomere length in human cells focusing on sex that all together with different environmental and hormonal regulations as well as parental aspect affect telomere attrition rate. We also raise some limitations in the assessment of telomere length that hinders a trustworthy meta-analysis that might lead to acknowledgment of the real value of this parameter.

biochemistry & molecular biology
A pro longevity role for cellular senescence

Amany Attaallah,Monia Lenzi,Silvia Marchionni,Giacomo Bincoletto,Veronica Cocchi,Eleonora Croco,Patrizia Hrelia,Silvana Hrelia,Christian Sell,Antonello Lorenzini

DOI: https://doi.org/10.1007/s11357-019-00066-2

2019-05-16

GeroScience

Abstract:Cellular senescence is a fundamental process that may play positive or detrimental roles for the organism. It is involved in tissue development and in tumor prevention although during aging is becoming a detrimental process contributing to the decline of tissue functions. In previous investigations, we have uncovered a better capacity to detect DNA damage in cells from long-lived mammals. Here, we report that cultured cells derived from long-lived species have a higher propensity to undergo senescence when challenged with DNA damage than cells derived from short-lived species. Using a panel of cells derived from six mammals, which range in lifespan from 3-4 years up to 120 years, we examined cell cycle response, induction of apoptosis and of cellular senescence. All species exhibited a cell cycle arrest while induction of apoptosis was variable. However, a significant positive correlation was found between the relative percent of cells, within a population which entered senescence following damage, and the lifespan of the species. We suggest that cellular senescence may have a positive role during development allowing it to contribute to the evolution of longevity.

geriatrics & gerontology,gerontology
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

C.M. Counter,A.A. Avilion,C.E. LeFeuvre,N.G. Stewart,C.W. Greider,C.B. Harley,S. Bacchetti

DOI: https://doi.org/10.1002/j.1460-2075.1992.tb05245.x

1992-05-01

The EMBO Journal

Abstract:Loss of telomeric DNA during cell proliferation may play a role in ageing and cancer. Since telomeres permit complete replication of eukaryotic chromosomes and protect their ends from recombination, we have measured telomere length, telomerase activity and chromosome rearrangements in human cells before and after transformation with SV40 or Ad5. In all mortal populations, telomeres shortened by approximately 65 bp/generation during the lifespan of the cultures. When transformed cells reached crisis, the length of the telomeric TTAGGG repeats was only approximately 1.5 kbp and many dicentric chromosomes were observed. In immortal cells, telomere length and frequency of dicentric chromosomes stabilized after crisis. Telomerase activity was not detectable in control or extended lifespan populations but was present in immortal populations. These results suggest that chromosomes with short (TTAGGG)n tracts are recombinogenic, critically shortened telomeres may be incompatible with cell proliferation and stabilization of telomere length by telomerase may be required for immortalization.
Telomeres and telomerase in stem cells during aging and disease.

Z Ju,K L Rudolph

DOI: https://doi.org/10.1159/000092502

2006-01-01

Abstract:Cell cycle checkpoints induced by telomere dysfunction represent one of the major in vivo tumor suppressor mechanisms preventing cancer but at the same time provoking age dependent decline in self-renewal and regeneration of tissues and organs. On the other hand, telomere shortening contributes to the initiation of cancer by inducing chromosomal instability. Telomere function and telomerase activity are mainly associated with actively proliferating cells. Since stem cells are continuously proliferating throughout lifetime, it is of great interest to explore the role of telomeres and telomerase in stem cells. Although most stem cell compartments express telomerase, the level of telomerase activity is not sufficient to maintain telomere length of stem cells during aging. Stem cells appear to have tighter DNAdamage checkpoint control in comparison to somatic cells, which may reflect the need to protect this long lasting cell compartment against malignant transformation. These enhanced checkpoint responses may have a detrimental impact on stem cell function, by causing increased sensitivity towards senescence or apoptosis induced by telomere shortening. This review summarizes our knowledge on telomere dynamics and its functional impact on stem cells during aging and transformation.
The tumor suppression theory of aging

Alexander M Wolf,Alexander M. Wolf

DOI: https://doi.org/10.1016/j.mad.2021.111583

IF: 5.498

2021-12-01

Mechanisms of Ageing and Development

Abstract:Despite continued increases in human life expectancy, the factors determining the rate of human biological aging remain unknown. Without understanding the molecular mechanisms underlying aging, efforts to prevent aging are unlikely to succeed. The tumor suppression theory of aging introduced here proposes somatic mutation as the proximal cause of aging, but postulates that oncogenic transformation and clonal expansion, not functional impairment, are the relevant consequences of somatic mutation. Obesity and caloric restriction accelerate and decelerate aging due to their effect on cell proliferation, during which most mutations arise. Most phenotypes of aging are merely tumor-suppressive mechanisms that evolved to limit malignant growth, the dominant age-related cause of death in early and middle life. Cancer limits life span for most long-lived mammals, a phenomenon known as Peto's paradox. Its conservation across species demonstrates that mutation is a fundamental but hard limit on mammalian longevity. Cell senescence and apoptosis and differentiation induced by oncogenes, telomere shortening or DNA damage evolved as a second line of defense to limit the tumorigenic potential of clonally expanding cells, but accumulating senescent cells, senescence-associated secretory phenotypes and stem cell exhaustion eventually cause tissue dysfunction and the majority, if not most, phenotypes of aging.

cell biology,geriatrics & gerontology,gerontology
Telomeres and the natural lifespan limit in humans

Troels Steenstrup,Jeremy D. Kark,Simon Verhulst,Mikael Thinggaard,Jacob V. B. Hjelmborg,Christine Dalgård,Kirsten Ohm Kyvik,Lene Christiansen,Massimo Mangino,Timothy D. Spector,Inge Petersen,Masayuki Kimura,Athanase Benetos,Carlos Labat,Ronit Sinnreich,Shih-Jen Hwang,Daniel Levy,Steven C. Hunt,Annette L. Fitzpatrick,Wei Chen,Gerald S. Berenson,Michelangela Barbieri,Giuseppe Paolisso,Shahinaz M. Gadalla,Sharon A. Savage,Kaare Christensen,Anatoliy I. Yashin,Konstantin G. Arbeev,Abraham Aviv

DOI: https://doi.org/10.18632/aging.101216

2017-04-06

Aging

Abstract:An ongoing debate in demography has focused on whether the human lifespan has a maximal natural limit. Taking a mechanistic perspective, and knowing that short telomeres are associated with diminished longevity, we examined whether telomere length dynamics during adult life could set a maximal natural lifespan limit. We define leukocyte telomere length of 5 kb as the 'telomeric brink', which denotes a high risk of imminent death. We show that a subset of adults may reach the telomeric brink within the current life expectancy and more so for a 100-year life expectancy. Thus, secular trends in life expectancy should confront a biological limit due to crossing the telomeric brink.
Longevity, stress response, and cancer in aging telomerase-deficient mice

K L Rudolph,S Chang,H W Lee,M Blasco,G J Gottlieb,C Greider,R A DePinho

DOI: https://doi.org/10.1016/s0092-8674(00)80580-2

IF: 64.5

1999-03-05

Cell

Abstract:Telomere maintenance is thought to play a role in signaling cellular senescence; however, a link with organismal aging processes has not been established. The telomerase null mouse provides an opportunity to understand the effects associated with critical telomere shortening at the organismal level. We studied a variety of physiological processes in an aging cohort of mTR-/- mice. Loss of telomere function did not elicit a full spectrum of classical pathophysiological symptoms of aging. However, age-dependent telomere shortening and accompanying genetic instability were associated with shortened life span as well as a reduced capacity to respond to stresses such as wound healing and hematopoietic ablation. In addition, we found an increased incidence of spontaneous malignancies. These findings demonstrate a critical role for telomere length in the overall fitness, reserve, and well being of the aging organism.
Telomere Reprogramming and Cellular Metabolism: Is There a Link?

Maria P Rubtsova,Denis A Nikishin,Mikhail Y Vyssokikh,Maria S Koriagina,Andrey V Vasiliev,Olga A Dontsova

DOI: https://doi.org/10.3390/ijms251910500

2024-09-29

Abstract:Telomeres-special DNA-protein structures at the ends of linear eukaryotic chromosomes-define the proliferation potential of cells. Extremely short telomeres promote a DNA damage response and cell death to eliminate cells that may have accumulated mutations after multiple divisions. However, telomere elongation is associated with the increased proliferative potential of specific cell types, such as stem and germ cells. This elongation can be permanent in these cells and is activated temporally during immune response activation and regeneration processes. The activation of telomere lengthening mechanisms is coupled with increased proliferation and the cells' need for energy and building resources. To obtain the necessary nutrients, cells are capable of finely regulating energy production and consumption, switching between catabolic and anabolic processes. In this review, we focused on the interconnection between metabolism programs and telomere lengthening mechanisms during programmed activation of proliferation, such as in germ cell maturation, early embryonic development, neoplastic lesion growth, and immune response activation. It is generally accepted that telomere disturbance influences biological processes and promotes dysfunctionality. Here, we propose that metabolic conditions within proliferating cells should be involved in regulating telomere lengthening mechanisms, and telomere length may serve as a marker of defects in cellular functionality. We propose that it is possible to reprogram metabolism in order to regulate the telomere length and proliferative activity of cells, which may be important for the development of approaches to regeneration, immune response modulation, and cancer therapy. However, further investigations in this area are necessary to improve the understanding and manipulation of the molecular mechanisms involved in the regulation of proliferation, metabolism, and aging.

Distribution of particles which produces a desired radiation pattern

Telomere control of replicative lifespan

Telomere length maintenance in aging and carcinogenesis.

Moderate stem cell telomere shortening rate postpones cancer onset in stochastic model

On the comparative biology of mammalian telomeres: Telomere length co-evolves with body mass, lifespan and cancer risk

Telomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan.

Telomeres, aging and cancer: In search of a happy ending

Telomere shortening and ageing

Telomere Length Dynamics and the Evolution of Cancer Genome Architecture

Mouse Model: Telomeres and Telomerase in Stem Cell and Cancer

How Will Telomeric Complex Be Further Contributed to Our Longevity? — the Potential Novel Biomarkers of Telomere Complex Counteracting Both Aging and Cancer

Telomere length, stem cells and aging

Telomere length: how the length makes a difference

A pro longevity role for cellular senescence

Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Telomeres and telomerase in stem cells during aging and disease.

The tumor suppression theory of aging

Telomeres and the natural lifespan limit in humans

Longevity, stress response, and cancer in aging telomerase-deficient mice

Telomere Reprogramming and Cellular Metabolism: Is There a Link?